Get 40% Off
🤑 This hedge fund gained 26.16% in the last month. Get their top stocks with our free stock ideas tool.See stock ideas

Cigna's 2017 growth may include Medicare Advantage acquisitions

Published 21/06/2017, 19:59
© Reuters. Cigna CEO David Cordani is interviewed at Reuters Health Summit 2014 in Washington
CI
-
ELV
-
HUM
-

By Caroline Humer

NEW YORK (Reuters) - Cigna Corp (N:CI) Chief Executive David Cordani told investors on Wednesday that the company has $7 billion (£6.3 billion) to $14 billion in capital it could use in 2017 for mergers and acquisitions in several areas, including Medicare Advantage for older people.

Cordani, speaking during the company's first meeting with investors since its deal to be bought by Anthem Inc (N:ANTM) officially broke off last month, also said the company would do at least $2 billion in share buybacks this year and set a target of $16 in earnings per share for 2021.

He said M&A areas that the No. 5 health insurer is considering also include growing internationally and building out its pharmacy and physician-related businesses, its retail capabilities and its government risk-based insurance programs.

Cigna has a pharmacy management business that it is looking to expand both internally and through acquisitions, Cordani said.

But the most attention regarding Cigna's M&A prospects on Wednesday was around rival Humana Inc (N:HUM), where Medicare Advantage accounts for two-thirds of revenue.

Several Wall Street analysts have recently written research notes about the merits of Cigna buying Humana, a deal they said had been under consideration before the Anthem deal was made two years ago.

When an investor asked if Cigna was as interested now in building its Medicare Advantage business as it was two years ago, Cordani confirmed that was the case.

In an interview, Cordani declined to discuss the possibility that the company is interested in buying Humana or give a size or timing for any acquisitions.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

"We tend not to get too fixated on the headlines," Cordani said. The company considers deals based on if they create value for shareholders and moves ahead if they do, he said.

Shares of Cigna were up 0.2 percent and Humana gained 1.2 percent in afternoon trading.

OBAMACARE INDIVIDUAL MARKETS

Cordani said Cigna has filed premium rates to stay in the same seven states where it now offers Obamacare individual plans for 2018, but that the company is waiting to make a final decision about its participation.

Republicans and U.S. President Donald Trump have pledged to repeal the Affordable Care Act, also known as Obamacare. Insurers deciding about participation must submit rates to HealthCare.gov by the end of Wednesday, but can withdraw as late as September.

Cigna's decision depends on new government rules or regulations for insurance or legislation, including whether the government will continue to fund the cost-sharing subsidies that affect individuals' out-of-pocket payments, it said.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.